CORCEPT THERAPEUTICS INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 30, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Jul 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 29, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 27, 2026 | Wolfe Research | downgrade | Peer Perform → Underperform | — | 53% |
| May 28, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 13, 2026 | UBS | upgrade | Neutral → Buy | — | 54% |
| May 4, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 1, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 26, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 26, 2026 | Wolfe Research | upgrade | Underperform → Peer Perform | — | 53% |
| Mar 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 25, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Feb 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $67 | 44% |
| Jan 23, 2026 | Canaccord Genuity | maintain | Buy → Buy | $100 | 48% |
| Jan 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $105 | 44% |
| Jan 2, 2026 | Canaccord Genuity | maintain | Buy → Buy | $99 | 48% |
| Jan 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $90 | 44% |
| Dec 16, 2025 | UBS | initiate | — → Neutral | $95 | 54% |
| Nov 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $145 | 44% |
| Nov 18, 2025 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $145 | 44% |
| Oct 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $145 | 44% |
| Sep 25, 2025 | Canaccord Genuity | maintain | Buy → Buy | $140 | 48% |
| Sep 10, 2025 | Canaccord Genuity | maintain | Buy → Buy | $140 | 48% |
| Aug 1, 2025 | Canaccord Genuity | maintain | Buy → Buy | $137 | 48% |
| Aug 1, 2025 | Piper Sandler | maintain | Overweight → Overweight | $121 | 54% |
| May 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $145 | 44% |
| Apr 3, 2025 | Piper Sandler | maintain | Overweight → Overweight | $131 | 54% |
| Apr 1, 2025 | Canaccord Genuity | maintain | Buy → Buy | $142 | 48% |
| Mar 31, 2025 | Truist Securities | maintain | Buy → Buy | $150 | 54% |
| Mar 31, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $150 | 44% |
| Feb 27, 2025 | Piper Sandler | maintain | Overweight → Overweight | $78 | 54% |
| Feb 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $115 | 44% |
| Feb 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $115 | 44% |
| Feb 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Jan 30, 2025 | Canaccord Genuity | maintain | Buy → Buy | $130 | 48% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Oct 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $80 | 44% |
| Sep 30, 2024 | Truist Securities | maintain | Buy → Buy | $76 | 54% |
| Sep 18, 2024 | Piper Sandler | maintain | Overweight → Overweight | $67 | 54% |
| Jul 31, 2024 | Canaccord Genuity | maintain | Buy → Buy | $78 | 48% |
| Jul 30, 2024 | Canaccord Genuity | maintain | Buy → Buy | $38 | 48% |
| Jul 30, 2024 | Piper Sandler | maintain | Overweight → Overweight | $38 | 54% |
| Jul 30, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Jul 1, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $35 | 54% |
| Jun 17, 2024 | Truist Securities | maintain | Buy → Buy | $65 | 54% |
No cross-platform signals in the last 90 days